Thyrocare, a leading provider of diagnostic and preventive healthcare services, has recently acquired Polo Labs’ pathology diagnostic business. This move is set to broaden Thyrocare’s presence in Northern India.
Thyrocare, which was acquired by API Holdings on June 25, 2021, for $613 million, has raised a total of $63.6 million to date. Polo Labs, based in Northern India, operates 14 laboratories across Punjab, Haryana, Himachal Pradesh, and Jammu & Kashmir, offering affordable and accessible diagnostic services. The lab utilizes advanced technology and equipment to meet high-quality standards.
Thyrocare has stated that this acquisition aligns with its strategic goal of enhancing diagnostic services and expanding its reach throughout India.
Founded by Arokiaswamy Velumani, Thyrocare is a fully automated diagnostic laboratory known for delivering quality reports at cost-effective prices to various laboratories and hospitals in India and abroad. The company is based in Mumbai and claims to serve over 2,000 cities both domestically and internationally.
